Table 1.

Demographics and baseline characteristics

CharacteristicPlacebo BID and carbo/paclitaxel (N = 53)Veliparib BID and carbo/paclitaxel (N = 105)
Median age (range), y62 (46–79)63 (33–84)
Sex, n (%)
 Male32 (60)75 (71)
 Female21 (40)30 (29)
Race
 White52 (98)102 (97)
 Black1 (2)2 (2)
 American Indian/Alaskan Native0 (0)1 (1)
Histology, n (%)
 Squamous25 (47)51 (49)
 Nonsquamous28 (53)54 (51)
Smoking history, n (%)
 Current31 (58)64 (61)
 Former14 (26)28 (27)
 Never8 (15)13 (12)
EGFR status, n (%)
 Wild-type49 (92)91 (87)
 Missing4 (8)14 (13)
Tumor burden at time of enrollment, n (%)
 Locally advanced15 (28)22 (21)
 Metastatic38 (72)83 (79)
Baseline ECOG, n (%)
 017 (32)35 (33)
 136 (68)70 (67)
  • Abbreviations: carbo, carboplatin.